link |
link |
xml |
html |
Genetic Testing Report |
2.16.840.1.113883.10.20.20 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Summary Section |
2.16.840.1.113883.10.20.20.1.1 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Overall Interpretation Section |
2.16.840.1.113883.10.20.20.1.1.1 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Recommendations Section |
2.16.840.1.113883.10.20.20.1.1.5 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Summary Of Tests Performed Section |
2.16.840.1.113883.10.20.20.1.1.6 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Test Performed Section |
2.16.840.1.113883.10.20.20.1.10 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Indications Section |
2.16.840.1.113883.10.20.20.1.11 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Findings Section |
2.16.840.1.113883.10.20.20.1.12 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Interpretation Section |
2.16.840.1.113883.10.20.20.1.13 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Specimen Section |
2.16.840.1.113883.10.20.20.1.7 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Test Details Section |
2.16.840.1.113883.10.20.20.1.8 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Test Information Section |
2.16.840.1.113883.10.20.20.1.9 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Background Section |
2.16.840.1.113883.10.20.20.1.9.1 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Methodology Section |
2.16.840.1.113883.10.20.20.1.9.2 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
References Section |
2.16.840.1.113883.10.20.20.1.9.3 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Clinical Genomic Statement |
2.16.840.1.113883.10.20.20.2 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Clinical Genomic Statement Genetic Variation |
2.16.840.1.113883.10.20.20.2.1 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Genetic Variation Associated Observation Amino Acid Change |
2.16.840.1.113883.10.20.20.2.1.1 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Genetic Variation Associated Observation Amino Acid Change Type |
2.16.840.1.113883.10.20.20.2.1.1.1 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Genetic Variation Associated Observation D N A Change |
2.16.840.1.113883.10.20.20.2.1.2 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Genetic Variation Associated Observation D N A Change Type |
2.16.840.1.113883.10.20.20.2.1.2.1 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Genetic Variation Associated Observation D N A Region Name |
2.16.840.1.113883.10.20.20.2.1.3 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Genetic Variation Associated Observation Zygosity |
2.16.840.1.113883.10.20.20.2.1.4 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Genetic Variation Associated Observation Gene Identifier |
2.16.840.1.113883.10.20.20.2.1.5 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Genetic Variation Associated Observation Transcript Reference Sequence Identifier |
2.16.840.1.113883.10.20.20.2.1.6 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Genetic Variation Associated Observation D N A Sequence Variation Identifier |
2.16.840.1.113883.10.20.20.2.1.7 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Genetic Variation Associated Observation Genomic Reference Sequence Identifier |
2.16.840.1.113883.10.20.20.2.1.8 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Clinical Genomic Statement Cytogenetics |
2.16.840.1.113883.10.20.20.2.2 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Cytogenetics Associated Observation Cells Analyzed Count |
2.16.840.1.113883.10.20.20.2.2.1 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Cytogenetics Associated Observation Cells Count |
2.16.840.1.113883.10.20.20.2.2.2 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Cytogenetics Associated Observation Cells Karyotyped Count |
2.16.840.1.113883.10.20.20.2.2.3 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Cytogenetics Associated Observation Colonies Count |
2.16.840.1.113883.10.20.20.2.2.4 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Cytogenetics Associated Observation I S C N Band Level |
2.16.840.1.113883.10.20.20.2.2.5 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Clinical Genomic Statement Gene Expression |
2.16.840.1.113883.10.20.20.2.3 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Clinical Genomic Statement Overall Interpretation |
2.16.840.1.113883.10.20.20.2.4 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Interpretive Phenotype |
2.16.840.1.113883.10.20.20.2.5 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Interpretive Phenotype Cytogenetics |
2.16.840.1.113883.10.20.20.2.5.1 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Interpretive Phenotype Gene Expression |
2.16.840.1.113883.10.20.20.2.5.2 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Interpretive Phenotype Genetic Variation |
2.16.840.1.113883.10.20.20.2.5.3 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Interpretive Phenotype Pharmacogenomic |
2.16.840.1.113883.10.20.20.2.5.4 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Interpretive Phenotype Pharmacogenomic Drug Efficacy |
2.16.840.1.113883.10.20.20.2.5.4.1 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Interpretive Phenotype Pharmacogenomic Drug Metabolism |
2.16.840.1.113883.10.20.20.2.5.4.2 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Overall Interpretive Phenotype Chromosome Analysis |
2.16.840.1.113883.10.20.20.2.5.4.3 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Overall Interpretive Phenotype Genetic Disease |
2.16.840.1.113883.10.20.20.2.5.5 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Overall Interpretive Phenotype Genetic Disease Carrier |
2.16.840.1.113883.10.20.20.2.5.6 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Overall Interpretive Phenotype Pharmacogenomic Drug Efficacy |
2.16.840.1.113883.10.20.20.2.5.7 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Overall Interpretive Phenotype Pharmacogenomic Drug Metabolism |
2.16.840.1.113883.10.20.20.2.5.8 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Genomic Source Class |
2.16.840.1.113883.10.20.20.3.2 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Indication Observation |
2.16.840.1.113883.10.20.20.3.3 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Genetic Disease Assessed Indication Observation |
2.16.840.1.113883.10.20.20.3.3.1 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Medication Assessed Indication Observation |
2.16.840.1.113883.10.20.20.3.3.2 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Test Performed Observation |
2.16.840.1.113883.10.20.20.3.4 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Genomic Associated Observation |
2.16.840.1.113883.10.20.20.4 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Genomic Observations Organizer |
2.16.840.1.113883.10.20.20.5.1 |
2013-02-01T00:00:00 |
|
Draft |
|
link |
link |
xml |
html |
Genomic Observation Reference |
2.16.840.1.113883.10.20.20.6 |
2013-02-01T00:00:00 |
|
Draft |
|